LifeMD (NASDAQ:LFMD) PT Raised to $14.00

LifeMD (NASDAQ:LFMD) had its target price hoisted by analysts at BTIG Research from $13.00 to $14.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s price objective suggests a potential upside of 25.45% from the stock’s previous close.

Separately, HC Wainwright increased their price objective on shares of LifeMD from $10.00 to $12.00 and gave the company a “buy” rating in a research report on Thursday, January 11th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $10.40.

LifeMD Price Performance

Shares of LFMD opened at $11.16 on Tuesday. LifeMD has a fifty-two week low of $1.40 and a fifty-two week high of $12.01. The firm’s 50 day moving average price is $9.25 and its 200 day moving average price is $7.70. The company has a market cap of $450.53 million, a P/E ratio of -15.94 and a beta of 1.43. The company has a quick ratio of 1.15, a current ratio of 1.22 and a debt-to-equity ratio of 3.22.

LifeMD (NASDAQ:LFMD) last announced its earnings results on Monday, March 11th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.02. The business had revenue of $44.86 million for the quarter, compared to analysts’ expectations of $40.65 million. On average, research analysts forecast that LifeMD will post -0.14 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of LFMD. Dorsey Wright & Associates acquired a new stake in LifeMD during the 3rd quarter worth $37,000. Tower Research Capital LLC TRC boosted its stake in LifeMD by 266.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $38,000 after purchasing an additional 3,348 shares during the period. HighMark Wealth Management LLC acquired a new stake in LifeMD during the 3rd quarter worth $38,000. Worth Venture Partners LLC acquired a new stake in shares of LifeMD in the 3rd quarter worth $64,000. Finally, Freedom Wealth Alliance LLC purchased a new stake in shares of LifeMD in the third quarter valued at about $68,000. 35.52% of the stock is owned by hedge funds and other institutional investors.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.